Barbara Weber

Insider Reports History

Location
Redwood City, CA
Signature
/s/ Daniella Beckman, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Barbara Weber:

Form 4 holding Director, Executive Chair, Director

Tango Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
222,132
Estimated value
Report date
02 Feb 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Revolution Medicines, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
15,955
Estimated value
Report date
20 Jun 2024
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Barbara Weber

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .